Are Altium (ASX:ALU) shares a buy right now?

Shaw and Partners' Jules Cooper says yes. He explains why COVID-19 was so tough on the business and why it will recover well.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Former market darling Altium Limited (ASX: ALU) has had a rough time of it lately.

The software firm's shares have come off about 30% from their 52-week high to trade at $28.67 at the time of writing. The Altium share price peaked at $41.82 in February 2020, just before the COVID-19 market crash.

So is this a buying opportunity, or has the business fundamentally changed in recent times?

Shaw and Partners senior analyst Jules Cooper admitted the coronavirus downturn "hit the business hard", but maintains its potential hasn't altered.

"I don't think they were having broader issues [when the pandemic hit]," he told the Direct From The Desk podcast.

"The business entered COVID with quite a lot of momentum — they were releasing new products and all was going swimmingly well."

Boy holding chalk board depicting buy and sell options for ASX shares.

Image source: Getty Images

We've just turned bullish on Altium

According to Shaw and Partners portfolio manager James Gerrish, his team had only recently "turned bullish" on Altium shares, now well down from their highs.

Shaw and Partners now rates the Altium share price as a 'buy' with a price target of $34.

"We've always loved the company, the product and the management team — [but] it's just always been priced to perfection." said Cooper.

"Now I feel we have an opportunity to buy a very high-quality business run by a high-quality team in a big global market. And we don't feel like we have to wince when we put the recommendation on our research."

Cooper's team uses cash EBITDA to work out the price-to-earnings (P/E) ratio for a company like Altium.

On that metric, it is currently selling for a multiple of around 33 times. Achieving the $34 price target would take it up to 43, which is still well down on its all-time peak.

"If you look back to December 2020… it was trading almost 50 times cash EBITDA," said Cooper.

Arguably, purchasing Altium shares now could allow for the earnings to recover in the coming years as discretionary corporate spend picks up among potential clients.

Why COVID was so tough on Altium

Altium provides software that designs printed circuit boards, which are one of the building blocks for computers.

Cooper explained that when COVID-19 struck last year, Altium was in the midst of transitioning from an upfront licensing model to recurring subscriptions.

Such a change stings the bottom line for software vendors in the short term, but is more lucrative in the long run.

"It's unfortunate that they made this transition at a time when it was difficult for the business," said Cooper.

"But I find it quite amusing that people will not give the company and the management team the premium they deserve, that they've built up over a very long period."

Cooper predicts Altium will accelerate its shift to recurring revenue by funneling the clientele returning to the company post-COVID onto that model.

Altium has previously earmarked a revenue target of $500 million by the 2025 financial year. It last reported $268.4 million for the 2020 financial year.

Tony Yoo owns shares of Altium. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and recommends Altium. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Man sitting in a plane seat works on his laptop.
Broker Notes

Down 34% in 2026, are Virgin Australia shares a good buy today?

A leading analyst delivers his outlook for Virgin Australia’s beaten-down shares.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Why these ASX shares are rated as buys in April

Let's see what makes them bullish on these names right now.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Are CBA shares still a good buy for passive income?

A leading analyst delivers his verdict on CBA’s passive income appeal.

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Broker Notes

Morgans names 2 ASX shares to buy and 1 to accumulate

What is the broker recommending investors do with these shares?

Read more »

A man in a business suit rides a graphic image of an arrow that is rebounding on a graph.
Broker Notes

2 ASX 200 shares to buy ahead of anticipated rally: expert

After a 9.1% drop between 27 February and 23 March, the ASX 200 reversed course last Tuesday.

Read more »

A group of people in a corporate setting do a collective high five.
Broker Notes

3 reasons to buy Ramsay Health Care shares today

A leading analyst expects Ramsay Health Care shares to keep outperforming in the months ahead.

Read more »

A woman presenting company news to investors looks back at the camera and smiles.
Broker Notes

Bell Potter says this ASX 200 stock can rise 38% and pay a 6% dividend yield

Major upside and a generous dividend yield could be on offer with this name.

Read more »